UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 180 filers reported holding UNIQURE NV in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,375 | -46.7% | 38,804 | -8.9% | 0.01% | -44.4% |
| Q2 2023 | $488,276 | -5.7% | 42,607 | +53.3% | 0.02% | -5.3% |
| Q2 2022 | $518,000 | +44.3% | 27,800 | +60.6% | 0.02% | +18.8% |
| Q4 2021 | $359,000 | -61.5% | 17,314 | -42.8% | 0.02% | -73.3% |
| Q2 2021 | $932,000 | -24.4% | 30,258 | -11.3% | 0.06% | +13.2% |
| Q4 2020 | $1,233,000 | +99.8% | 34,122 | +103.8% | 0.05% | +82.8% |
| Q3 2020 | $617,000 | -35.5% | 16,746 | -21.2% | 0.03% | -40.8% |
| Q2 2020 | $957,000 | +13.5% | 21,243 | +19.6% | 0.05% | -19.7% |
| Q1 2020 | $843,000 | +205.4% | 17,765 | +153.3% | 0.06% | +335.7% |
| Q3 2019 | $276,000 | – | 7,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |